These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

282 related items for PubMed ID: 25002377

  • 1. Combining radiofrequency ablation and ethanol injection may achieve comparable long-term outcomes in larger hepatocellular carcinoma (3.1-4 cm) and in high-risk locations.
    Lin JW, Lin CC, Chen WT, Lin SM.
    Kaohsiung J Med Sci; 2014 Aug; 30(8):396-401. PubMed ID: 25002377
    [Abstract] [Full Text] [Related]

  • 2. Combined percutaneous radiofrequency ablation and ethanol injection for hepatocellular carcinoma in high-risk locations.
    Wong SN, Lin CJ, Lin CC, Chen WT, Cua IH, Lin SM.
    AJR Am J Roentgenol; 2008 Mar; 190(3):W187-95. PubMed ID: 18287411
    [Abstract] [Full Text] [Related]

  • 3. [Randomized clinical trial of percutaneous radiofrequency ablation plus absolute ethanol injection compared with radiofrequency ablation alone for small hepatocellular carcinoma].
    Chen MS, Zhang YJ, Li JQ, Liang HH, Zhang YQ, Zheng Y.
    Zhonghua Zhong Liu Za Zhi; 2005 Oct; 27(10):623-5. PubMed ID: 16438875
    [Abstract] [Full Text] [Related]

  • 4. Combined ethanol injection therapy and radiofrequency ablation therapy in percutaneous treatment of hepatocellular carcinoma larger than 4 cm.
    Vallone P, Catalano O, Izzo F, Siani A.
    Cardiovasc Intervent Radiol; 2006 Oct; 29(4):544-51. PubMed ID: 16528626
    [Abstract] [Full Text] [Related]

  • 5. Hepatocellular carcinoma downstaging in liver transplantation.
    Yu CY, Ou HY, Huang TL, Chen TY, Tsang LL, Chen CL, Cheng YF.
    Transplant Proc; 2012 Mar; 44(2):412-4. PubMed ID: 22410030
    [Abstract] [Full Text] [Related]

  • 6. Single hepatocellular carcinoma smaller than 2 cm: are ethanol injection and radiofrequency ablation equally effective?
    Pompili M, De Matthaeis N, Saviano A, De Sio I, Francica G, Brunello F, Cantamessa A, Giorgio A, Scognamiglio U, Fornari F, Giangregorio F, Piscaglia F, Gualandi S, Caturelli E, Roselli P, Riccardi L, Rapaccini GL.
    Anticancer Res; 2015 Jan; 35(1):325-32. PubMed ID: 25550567
    [Abstract] [Full Text] [Related]

  • 7. Combined percutaneous radiofrequency ablation and ethanol injection versus hepatic resection for 2.1-5.0 cm solitary hepatocellular carcinoma: a retrospective comparative multicentre study.
    Chen S, Peng Z, Lin M, Chen Z, Hu W, Xie X, Liu L, Qian G, Peng B, Li B, Kuang M.
    Eur Radiol; 2018 Sep; 28(9):3651-3660. PubMed ID: 29600474
    [Abstract] [Full Text] [Related]

  • 8. Evaluation of transcatheter arterial embolization prior to percutaneous tumor ablation in patients with hepatocellular carcinoma: a randomized controlled trial.
    Akamatsu M, Yoshida H, Obi S, Sato S, Koike Y, Fujishima T, Tateishi R, Imamura M, Hamamura K, Teratani T, Shiina S, Ishikawa T, Omata M.
    Liver Int; 2004 Dec; 24(6):625-9. PubMed ID: 15566514
    [Abstract] [Full Text] [Related]

  • 9. Radiofrequency ablation versus resection for the treatment of early stage hepatocellular carcinoma: a multicenter Australian study.
    Gory I, Fink M, Bell S, Gow P, Nicoll A, Knight V, Dev A, Rode A, Bailey M, Cheung W, Kemp W, Roberts SK, Melbourne Liver Group.
    Scand J Gastroenterol; 2015 May; 50(5):567-76. PubMed ID: 25615260
    [Abstract] [Full Text] [Related]

  • 10. Radiofrequency ablation of hepatocellular carcinoma in difficult locations: Strategies and long-term outcomes.
    Yang W, Yan K, Wu GX, Wu W, Fu Y, Lee JC, Zhang ZY, Wang S, Chen MH.
    World J Gastroenterol; 2015 Feb 07; 21(5):1554-66. PubMed ID: 25663774
    [Abstract] [Full Text] [Related]

  • 11. [Radiofrequency ablation and percutaneous ethanol injection in patients with unresectable hepatocellular carcinoma--a comparative study using Japan Integrated Staging Score (JIS score) system].
    Morimoto M, Numata K, Sugimori K, Shirato K, Kokawa A, Oka H, Hirao M, Hirasawa K, Ko R, Saitou T, Imada T, Tanaka K.
    Gan To Kagaku Ryoho; 2005 Oct 07; 32(11):1592-5. PubMed ID: 16315880
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Comparison of resection and ablation for hepatocellular carcinoma: a cohort study based on a Japanese nationwide survey.
    Hasegawa K, Kokudo N, Makuuchi M, Izumi N, Ichida T, Kudo M, Ku Y, Sakamoto M, Nakashima O, Matsui O, Matsuyama Y.
    J Hepatol; 2013 Apr 07; 58(4):724-9. PubMed ID: 23178708
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Local ablative therapies in HCC: percutaneous ethanol injection and radiofrequency ablation.
    Mahnken AH, Bruners P, Günther RW.
    Dig Dis; 2009 Apr 07; 27(2):148-56. PubMed ID: 19546553
    [Abstract] [Full Text] [Related]

  • 18. Radiofrequency ablation plus chemoembolization versus radiofrequency ablation alone for hepatocellular carcinoma: a meta-analysis of randomized-controlled trials.
    Lu Z, Wen F, Guo Q, Liang H, Mao X, Sun H.
    Eur J Gastroenterol Hepatol; 2013 Feb 07; 25(2):187-94. PubMed ID: 23134976
    [Abstract] [Full Text] [Related]

  • 19. Increased survival in hepatocellular carcinoma with iodine-125 implantation plus radiofrequency ablation: a prospective randomized controlled trial.
    Chen K, Chen G, Wang H, Li H, Xiao J, Duan X, He J, He K, Xiang G.
    J Hepatol; 2014 Dec 07; 61(6):1304-11. PubMed ID: 25064436
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.